The 25 Most Valuable Biotech Companies in Europe in 2025
The biotech industry in Europe is booming, with companies making groundbreaking medical advances, from oncology and gene therapy to immunology and rar...
A relative newcomer to the biotech scene, Pharvaris was founded by the team that successfully exited to BioMarin in 2015. With a promising pipeline, including treatments for rare diseases, Pharvaris is quickly gaining attention from investors and the medical community.
Trusted by 350+ professionals from top companies like Argenx, BioNTech, or Genmab. No spam, no noise.